(Q46408397)

English

Analysis of EGFR gene amplification, protein over-expression and tyrosine kinase domain mutation in recurrent glioblastoma

scientific article published on 28 August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

Analysis of EGFR gene amplification, protein over-expression and tyrosine kinase domain mutation in recurrent glioblastoma (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

3

object named as

Almos Klekner

0 references

Kristof Egervari

object named as

Kristof Egervari

2

0 references

Zoltan Szollosi

object named as

Zoltan Szollosi

7

0 references

author name string

Judit Toth

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

Almos Klekner

3

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

Laszlo Bognar

4

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

Janos Szanto

5

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

Zoltan Nemes

6

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

publication date

28 August 2008

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

Pathology Oncology Research

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

15

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

225-229

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

https://scigraph.springernature.com/pub.10.1007/s12253-008-9082-4

0 references

Epidermal growth factor receptor antagonists: novel therapy for the treatment of high-grade gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of Epidermal Growth Factor Receptor Status by Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer Is Rare

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuropathology of malignant gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of gefitinib in recurrent glioblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR and cancer prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene expression profiling and genetic markers in glioblastoma survival.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Treatment of Malignant Gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatic mutations of EGFR in colorectal cancers and glioblastomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18752056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12253-008-9082-4

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752056

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46408397&oldid=2109897165"